US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 716.900
  • +20.020+2.87%
Close Jan 13 16:00 ET
  • 717.000
  • +0.100+0.01%
Post 16:02 ET
78.78BMarket Cap17.73P/E (TTM)

Regeneron Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jan 13, 2025

Based on 22 analysts giving stock ratings to Regeneron Pharmaceuticals in the past 3 months

Buy

  • Buy

    77.27%

  • Hold

    18.18%

  • Sell

    4.55%

Price Target

Updated: Jan 13, 2025

The average Regeneron Pharmaceuticals stock price target is 1066.81 with a max estimate of 1300.00 and a min estimate of 565.00

Review Regeneron Pharmaceuticals earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+4.06%
DexCom
DXCM
+2.70%
Collegium Pharmaceutical
COLL
+2.67%
Halozyme Therapeutics
HALO
+2.53%
Constellation Brands
STZ
+2.26%

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 13, 2025

Buy

  • Buy

    77.27%

  • Hold

    18.18%

  • Sell

    4.55%

Price Target

Updated: Jan 13, 2025

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.36%